Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intiva Pharma was a Colorado limited liability company associated with Jeffrey Friedland and Richard Greenberg, and appears to have operated primarily as an investment or holding vehicle rather than as a drug development biotechnology or pharmaceutical company. Public records and media coverage tie it to investments connected to the legal cannabis sector, including a strategic investment in agricultural technology company BreedIT. Available evidence does not indicate a therapeutic pipeline, clinical programs, or healthcare products and services typical of a life sciences operating company. Colorado business registry aggregators indicate the entity became delinquent and was dissolved in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intiva Pharma.